Benchling
Private Company
Total funding raised: $321.5M
Overview
Benchling is a leading provider of cloud-based informatics software for the life sciences industry, founded in 2012 and headquartered in San Francisco. Its core platform functions as a digital lab notebook and data hub, enabling scientists to plan, record, and analyze experiments while managing biological entities like DNA sequences and cell lines. The company has achieved significant market penetration, being used by over 1,300 biotech companies and more than half of the top 50 global biopharmas. Benchling's strategy focuses on leveraging AI and an open, flexible platform to increase research productivity and build a unified data foundation for computational science.
Technology Platform
Cloud-based, biology-first informatics platform integrating a digital lab notebook, biological registry, workflow automation, and AI tools for biotech R&D.
Funding History
5Opportunities
Risk Factors
Competitive Landscape
Benchling competes in the life sciences informatics market against large legacy vendors (e.g., Dassault BIOVIA, Thermo Fisher) moving to the cloud, and newer SaaS-focused startups. Its key differentiator is its integrated, biology-aware platform that combines ELN, registry, and workflow management in a single cloud-native system designed for modern R&D.